Evidence-Based Complementary and Alternative Medicine

Volume 2013 (2013), Article ID 852049, 10 pages

http://dx.doi.org/10.1155/2013/852049

Research Article

The In Vitro Antimicrobial Activity of Lavandula angustifolia Essential Oil in Combination with Other Aroma-Therapeutic Oils

Stephanie de Rapper,¹ Guy Kamatou,² Alvaro Viljoen,² and Sandy van Vuuren¹

¹Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Parktown, Johannesburg 2193, South Africa

²Department of Pharmaceutical Sciences, Faculty of Science, Tshwane University of Technology, Pretoria 0001, South Africa

Received 26 February 2013; Accepted 8 April 2013

Academic Editor: Jenny M. Wilkinson

Copyright © 2013 Stephanie de Rapper et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

The antimicrobial activity of Lavandula angustifolia essential oil was assessed in combination with 45 other oils to establish possible interactive properties. The composition of the selected essential oils was confirmed using GC-MS with a flame ionization detector. The microdilution minimum inhibitory concentration (MIC) assay was undertaken, whereby the fractional inhibitory concentration (ΣFIC) was calculated for the oil combinations. When lavender oil was assayed in 1 : 1 ratios with other oils, synergistic (26.7%), additive (48.9%), non-interactive (23.7%), and antagonistic (0.7%) interactions were observed. When investigating different ratios of the two oils in combination, the most favourable interactions were when L. angustifolia was combined with Cinnamomum zeylanicum or with Citrus sinensis, against C. albicans and S. aureus, respectively. In 1 : 1 ratios, 75.6% of the essential oils investigated showed either synergistic or additive results, lending in vitro credibility to the use of essential oil blends in aroma-therapeutic practices. Within the field of aromatherapy, essential oils are commonly employed in mixtures for the treatment of infectious diseases; however, very little evidence exists to support the use in combination. This study lends some credence to the concomitant use of essential oils blended with lavender.

1. Introduction

Essential oils, which form part of naturopathic therapy, are widely known for their antimicrobial properties. They have been found to be beneficial in the fields of dermatology, gastritis, respiratory complaints, wound healing, and genital infections. Of all the essential oils used commercially, lavender (Lavandula angustifolia) oil appears to be one of the most popular. The earliest therapeutic use of L. angustifolia Mill can be traced back to Roman and Greek times [1]. The significance of which, with respect to antimicrobial applications, has been further emphasised in a number of studies [2, 3]. Within aromatherapy and wellness industries, the oil has been indicated for the treatment of a plethora of conditions, such as rhinitis, wet coughs, minor burns, and in the emergency treatment of wounds [4].

Essential oils are not only used in monotherapy but have been used in combination for many years [5]. They are used to bring about healing in a holistic manner by stimulating the mind, body, and senses, where the combination is believed to act synergistically to further enhance these effects. After examining the literature on the application of various essential oils for their use in treating microbial infections, more than 600 possible essential oil combinations were identified, of which the majority included the use of L. angustifolia in combination for the treatment of infections [5–11]. According to the general literature, L. angustifolia has been used as an antibiotic or antiseptic in combination with a number of other oils (bitter orange, caraway, cederwood, chamomile, geranium, grapefruit, lemon, marjoram, patchouli, rosemary, sage, sweet orange, and ylang-ylang) [7–9]. In spite of the numerous references to L. angustifolia in combination with other essential oils, supporting evidence is lacking. Only two scientific papers were found where L. angustifolia was studied in combination with commercially available essential oils. Melaleuca alternifolia (tea tree oil) in combination with L. officinalis was investigated against Trichophyton rubrum and T. mentagrophytes var. interdigitale. The data confirmed that synergistic activity was evident when these oils were placed in combination [12]. Another study conducted by Edwards-Jones et al. [13] placed L. officinalis in combination with M. alternifolia, Pogostemon cablin, Pelargonium graveolens, and Citricidal (a grapefruit seed extract, commercially available as an antibacterial agent). The antibacterial efficacy was tested using the inhibition zone method, in which direct and vapour contact of the essential oils were tested. When placed in combination with P. graveolens and M. alternifolia, L. officinalis demonstrated an increased inhibitory effect against Staphylococcus aureus. Antagonism was noted for the combination of L. officinalis and M. alternifolia against methicillin-resistant S. aureus (MRSA). While these two studies provide confirmation of improved efficacy in some cases when the oils are used in combination, the overall interactive potential with other essential oils has not been fully explored. In aromatherapy practices, essential oils are rarely used individually but rather applied as blends to achieve a superior therapeutic effect. With this in mind, the aim of this study was to evaluate the interactive in vitro antimicrobial properties of L. angustifolia and a selection of essential oils commonly used in therapeutic combinations.

2. Materials and Methods

2.1. Essential Oil Selection and Chemical Composition Analysis

Forty-five essential oil samples were obtained as a gift from commercial fragrance and flavour suppliers. The composition of the selected essential oils was confirmed using gas chromatography coupled to a mass spectrometer and flame ionization detector (GC-MS-FID). The GC-MS-FID (Agilent 6890 N GC system and 5973 MS) was equipped with a HP-Innowax polyethylene glycol column (60 m × 250 μm i.d. × 0.25 μm film thickness). A volume of 1 μL of the essential oil was injected (using a split ratio of 200 : 1) with an autosampler at 24.79 psi and an inlet temperature of 250°C. The GC oven temperature was set at 60°C for 10 min, then 220°C at a rate of 4°C/min for 10 min and followed by a temperature of 240°C at a rate of 1°C/min. Helium was used as a carrier gas at a constant flow of 1.2 mL/min. Spectra was obtained on electron impact at 70 eV, scanning from 35 to 550 m/z. The percentage composition of the individual components was quantified by integration measurements, using flame ionization detection (FID, 250°C). Component identifications were made by comparing mass spectra from the total ion chromatogram, and retention indices using NIST and Mass Finder GC-MS libraries and major compounds given in Table 1 [14].

Table 1: The chemical composition (major compounds only) of the essential oils under investigation.

Essential oil
Major constituent
% Abundance

Abies balsamea
β-pinene
31.0

bornyl acetate
14.9

δ-3-carene
14.2

Andropogon muricatus
β-vetirenene
7.2

zizanol
12.6

λ-vetivenene
4.5

isoeremophilene
3.2

β-vetispirene
3.2

vetivenic acid
3.7

Angelica archangelica root
α-phellandrene
18.5

α-pinene
13.7

β-phellandrene
12.6

δ-3-carene
12.1

Angelica archangelica seed
β-phellandrene
59.2

Anthemis nobilis
2-methylbutyl-2-methyl propanoic acid
31.5

limonene
18.3

3-methylpentyl-2-butenoic acid
16.7

isobutyl isobutyrate
10.0

Artemisia dracunculus
estragole
82.6

Canarium luzonicum
limonene
41.9

elemol
21.6

α-phellandrene
11.4

Cananga odorata heads
benzyl acetate
31.9

linalool
27.0

methyl benzoate
10.4

Cananga odorata
bicyclosesquiphellandrene
19.5

β-farnesene
13.9

Carum carvi
limonene
27.6

carvone
67.5

Cinnamomum zeylanicum
eugenol
80.0

Citrus aurantium
linalyl acetate
54.9

linalool
21.1

Citrus grandis
limonene
74.8

Citrus sinensis
limonene
93.2

Commiphora myrrha
furanoeusdema-1,3-diene
57.7

lindestrene
16.3

Cupressus sempervirens
α-pinene
41.2

δ-3-carene
23.7

Cymbopogon citratus
geranial
44.8

Cymbopogon nardus
citronellal
38.3

geraniol
20.7

citronellol
18.8

Daucus carota
carotol
44.4

β-caryophyllene
5.7

β-bisabolene
5.3

Eucalyptus globulus
1,8-cineole
58.0

α-terpineol
13.2

Foeniculum dulce
E-anethole
79.1

Hyssopus officinalis
isopinocamphone
48.7

pinocamphone
15.5

Juniperus virginiana
thujopsene
29.8

cedrol
14.9

α-cedrene
12.4

Juniperus virginiana berries
α-pinene
20.5

myrcene
13.7

bicyclosesquiphellandrene
10.7

Laurus nobilis
eugenol
57.2

myrcene
14.3

chavicol
12.7

Lavandula angustifolia
linalyl acetate
36.7

linalool
31.4

terpinen-4-ol
14.9

Litsea cubeba
geranial
45.6

nerol
31.2

Matricaria chamomilla
bisabolene oxide A
46.9

β-farnesene
19.2

Melaleuca alternifolia
terpinen-4-ol
49.3

γ -terpinene
16.9

Melaleuca viridiflora
1,8-cineole
45.9

α-terpinene
21.0

Mentha piperita
menthol
47.5

menthone
18.6

Myrtus communis
myrtenyl acetate
28.2

1,8-cineole
25.6

α-pinene
12.5

Ocimum basilicum
linalool
54.1

Origanum majorana
1,8-cineole
46.0

linalool
26.1

Pelargonium odoratissimum
citronellol
34.2

geraniol
15.7

Pinus sylvestris
bornyl acetate
42.3

camphene
11.8

α-pinene
11.0

Piper nigrum
β-caryophyllene
33.8

limonene
16.4

Pogostemon patchouli
patchouli alcohol
37.3

α-bulnesene
14.6

α-guaiene
12.5

Rosmarinus officinalis
1,8-cineole
48.0

Salvia sclarea
linalyl acetate
72.9

linalool
11.9

Santalum album
α-santalol
32.1

Styrax benzoin
cinnamyl alcohol
44.8

benzene propanol
21.7

Syzygium aromaticum
eugenol
82.2

eugenol acetate
13.2

Tagetes patula
(E)-β-ocimene
41.3

E-tagetone
11.2

verbenone
10.9

Thymus vulgaris
p-cymene
39.9

thymol
20.7

γ -terpinene
8.3

2.2. Antimicrobial Assays

Seven laboratory cultured bacterial strains, three laboratory cultured fungal strains, and four clinical bacterial strains were selected for the study (Table 2). This was undertaken to provide a broad-spectrum profile of the antimicrobial activity for L. angustifolia. In order to evaluate combined efficacies, three microorganisms were selected (Staphylococcus aureus, ATCC 6538; Pseudomonas aeruginosa, ATCC 27858 and Candida albicans, ATCC 10231), whereby the oils were evaluated for antimicrobial activity using the microdilution minimum inhibitory concentration (MIC) assay [15]. Essential oils are typically used to treat topical and respiratory infections, and these microorganisms were selected on the basis of this pathogenesis. Furthermore, selection was based on the criteria to include a Gram-positive, a Gram-negative, and a yeast strain. The Clinical and Laboratory Standards Institute guidelines (CLSI) [16] were used to ensure that accurate microbiological assay and transfer techniques were followed. Stock cultures were retained at −20°C, subcultured onto Tryptone Soya (TSA) agar, and incubated at optimum temperatures (37°C for 24 h for bacteria, and 37°C for 48 h for the yeast). Isolated pure colonies were selected and transferred onto TSA and thereafter kept viable by subculturing weekly for stock culture maintenance.

Table 2: The antimicrobial effects of L. angustifolia essential oil against 14 test pathogens.

Microorganism
Reference strain no.
MIC*

Methicillin-resistant Staphylococcus aureus (MRSA)
ATCC 43300
2.00

Methicillin-resistant Staphylococcus aureus
Clinical strain
2.00

Methicillin-gentamicin resistant Staphylococcus aureus (MGRSA)
ATCC 33592
2.00

Staphylococcus aureus
ATCC 6538
2.00

Staphylococcus aureus
Clinical strain
2.00

Staphylococcus epidermidis
ATCC 2223
2.00

Staphylococcus epidermidis
Clinical strain
2.00

Vancomycin-resistant Enterococcus faecalis
ATCC 51299
2.00

Enterococcus faecalis
Clinical strain
2.00

Klebsiella pneumoniae
ATCC 13883
1.50

Pseudomonas aeruginosa
ATCC 27853
2.00

Cryptococcus neoformans
ATCC 11093
2.00

Candida tropicalis
ATCC 201380
0.75

Candida albicans
ATCC 10231
3.00

Ciprofloxacin
Positive control
0.20 × 10−3 to 0.60 × 10⁻³

Amphotericin B
Positive control
0.60 × 10⁻³

*MIC given in mg/mL.

Essential oils were diluted to a concentration of 32 mg/mL using acetone as the diluent. The microtitre plates were prepared by adding 100 μL of sterile, distilled water into each of the wells. Thereafter, the oils were added at a volume of 100 μL (when tested individually) and 50 : 50 μL (when tested in combination). The essential oils were serially diluted to yield concentrations of 8, 4, 2, 1, 0.5, 0.25, 0.125, and 0.0625 mg/mL. The microorganisms for testing were diluted using sterile TSB at a 1 : 100 dilution in order to achieve an approximate concentration of 1 × 10⁶ colony forming units (CFU)/mL. Cultures were added to all the wells of their respective microtitre plates, at a volume of 100 μL. The microtitre plates were then sealed with a sterile adhesive sealing film, to prevent any essential oil loss due to their inherent volatility. The microtitre plates were incubated under optimal conditions (37°C for 24 h for bacteria and 37°C for 48 h for yeasts). After incubation, 0.4 mg/mL of p-iodonitrotetrazolium violet solution (INT) was added to each well (40 μL). Viable micro-organisms interact with INT to create a colour change from clear to a red-purple colour. Thus the lowest dilution with no colour change was considered as the MIC for that oil [17].

For the 1 : 1 combinations, the fractional inhibitory concentration index (ΣFIC) was used to determine the interaction of the oils. The ΣFIC was calculated by dividing the MIC value of the combined essential oils with the MIC value of each essential oil placed in the combination. The ΣFIC was then calculated by adding these two values. The ΣFIC for each combination was interpreted as antagonistic where a ΣFIC value of greater than 4.00 is observed. Indifference was noted for ΣFIC values greater than 1.00 but less than or equal to 4.00. Additive properties for ΣFIC values more than 0.50 but less than or equal to 1.00, with synergistic properties noted for ΣFIC values less than or equal to 0.50 [18].

Isobolograms were constructed to determine what antimicrobial interactions could be apparent if variable concentrations of selection of oils (Daucus carota, Juniperus virginiana, Cinnamomum zeylanicum, and Citrus sinensis) were combined with L. angustifolia. Selection was based on promising synergistic interactions observed in the 1 : 1 ΣFIC analysis. Nine ratios, that is, 9 : 1; 8 : 2; 7 : 3; 6 : 4; 5 : 5; 4 : 6; 3 : 7; 2 : 8; and 1 : 9 of the oils were mixed and thereafter the MIC values were determined for these combinations, as well as for the essential oils independently. Isobolograms were plotted using GraphPad Prism, version five software to present the mean MIC values of the combinations as ratios [19]. The isobolograms were interpreted by examining the data points for each ratio in relation to the MIC values for the oils independently. All points between the 1.0 : 1.0 line and 4.0 : 4.0 line were classified as non-interactive. Points between the 0.5 : 0.5 and 1.0 : 1.0 line were interpreted as additive and points below or on the 0.5 : 0.5 line on the isobologram were interpreted as synergistic. Antagonism was identified as data points above the 4.0 : 4.0 line [18].

Positive and negative controls were included in all assays, with 0.01 mg/mL ciprofloxacin used as a positive control for bacteria, and 0.10 mg/mL amphotericin B for the yeast. The negative control was a water/acetone solution at a concentration of 32 mg/mL, to determine any antimicrobial activity of the diluent. Media and culture controls, such as Tryptone Soya broth (TSB), were included to confirm sterility and viability, respectively. Assays were done in triplicate and further repetitions conducted where necessary.

3. Results

3.1. Chemical Composition

The chemical composition of the essential oils were analysed in order to confirm the specific chemotypes (Table 1). Although a full chemical profile was established for each essential oil, only the major constituents have been noted for the sake of brevity. The major chemical compounds identified for the essential oils are congruent with previously published profiles.

3.2. Antimicrobial Analysis

The antimicrobial efficacy for L. angustifolia essential oil was investigated against 14 pathogens whereby MIC values of 2.00 mg/mL were predominantly observed against the tested pathogens. A few exceptions (Klebsiella pneumoniae with an MIC of 1.50 mg/mL, Candida tropicalis with an MIC of 0.75 mg/mL, and C. albicans with an MIC of 3.00 mg/mL) were noted (Table 2). When examining the entire panel of oils tested, Santalum album showed the greatest antimicrobial effect, with the lowest MIC values for S. aureus (MIC value of 0.25 mg/mL) and P. aeruginosa (MIC value of 0.50 mg/mL).

When the 45 essential oil samples were placed in combination with L. angustifolia in equal ratios, 75.6% of the combinations exhibited either synergistic or additive antimicrobial activity (Table 3). The most noteworthy synergistic interactions were evident for C. albicans, particularly the combination of L. angustifolia with Cupressus sempervirens (ΣFIC value of 0.15) and L. angustifolia with Litsea cubeba (ΣFIC value of 0.19). For all combinations studied, antagonism was only noted once, where Cymbopogon citratus was investigated in combination with L. angustifolia (ΣFIC value of 6.67). Some 1 : 1 combinations (L. angustifolia with either D. carota or J. virginiana or C. zeylanicum or C. sinensis) demonstrated synergistic interactions against both C. albicans and S. aureus. These combinations were analysed further against these microorganisms to determine if varied ratios of the two essential oils in the combination would yield varied interactions (Figure 1). The combination where L. angustifolia was combined with C. zeylanicum in various ratios against C. albicans displayed the greatest synergistic effect of all oils studied.

Table 3: The antimicrobial effects of the essential oils studied individually and in combination with L. angustifolia essential oil.

Essential oil
Oils examined individually
1 : 1 Combinations

C. albicans
S. aureus
P. aeruginosa
C. albicans
S. aureus
P. aeruginosa

(ATCC 10231)
(ATCC 6538)
(ATCC 27858)
(ATCC 10231)
(ATCC 6538)
(ATCC 27858)

MIC
MIC
MIC
MIC
ΣFIC
MIC
ΣFIC
MIC
ΣFIC

Abies balsamea
2.00
3.00
2.00
1.50
0.63
6.00
2.50
1.00
0.52

Andropogon muricatus
1.75
0.75
1.50
1.00
0.45
1.00
0.92
2.00
1.02

Angelica archangelica (seed)
2.00
2.00
2.00
2.00
0.83
4.00
2.00
1.00
0.75

Angelica archangelica (root)
2.00
1.75
2.00
1.00
0.42
2.00
1.07
1.00
0.67

Anthemis nobilis
3.00
16.00
2.00
1.00
0.33
3.00
0.84
1.00
0.54

Artemisia dracunculus
2.00
3.00
2.00
1.00
0.42
4.00
1.67
1.00
0.51

Canarium luzonicum
3.00
3.00
2.00
0.75
0.25
8.00
3.33
1.00
0.53

Cananga odorata (heads)
2.00
4.00
1.50
2.00
0.83
3.00
1.13
2.00
1.02

Cananga odorata
2.00
2.00
3.00
3.00
1.25
3.00
1.50
2.00
1.02

Carum carvi
2.00
2.00
2.00
1.00
0.42
2.00
1.00
1.00
0.56

Cinnamomum zeylanicum
2.00
2.00
1.50
1.00
0.40
1.00
0.50
1.00
0.53

Citrus aurantium
2.00
4.00
2.00
1.00
0.42
3.00
1.13
1.00
0.51

Citrus grandis
2.00
3.00
1.50
1.00
0.42
4.00
1.67
1.00
0.52

Citrus medica limonum
2.00
3.00
2.00
1.00
0.42
6.00
2.50
1.00
0.52

Citrus sinensis
2.00
4.00
2.00
1.00
0.42
1.00
0.38
1.00
0.51

Commiphora myrrha
4.00
2.00
4.00
1.00
0.29
2.00
1.00
2.00
1.03

Cupressus sempervirens
4.00
12.00
2.00
0.50
0.15
2.00
0.58
1.00
0.53

Cymbopogon citratus
2.00
1.67
1.50
0.50
6.67
1.00
0.55
1.00
0.52

Cymbopogon nardus
0.75
4.00
1.50
0.75
0.42
2.00
0.75
1.00
0.53

Daucus carota
3.00
2.00
3.00
1.50
0.50
1.00
0.50
1.00
0.56

Eucalyptus globulus
1.50
4.00
3.00
0.75
0.38
4.00
1.50
1.00
0.53

Foeniculum dulce
2.00
2.00
3.00
1.00
0.45
4.00
2.00
1.00
0.52

Hyssopus officinalis
1.00
3.00
2.00
0.50
0.33
4.00
1.67
1.00
0.52

Juniperus virginiana
1.50
2.00
2.00
1.00
0.50
1.00
0.50
1.00
0.55

Juniperus virginiana (berries)
2.00
3.00
2.00
0.50
0.21
3.00
1.25
1.00
0.52

Laurus nobilis
0.75
0.83
2.67
1.00
0.83
2.00
1.70
1.00
0.60

Litsea cubeba
6.00
1.50
1.50
0.75
0.19
2.00
1.17
1.00
0.52

Matricaria chamomilla
0.50
1.50
4.00
1.00
1.17
2.00
1.17
1.00
0.54

Melaleuca viridiflora
1.75
2.00
2.00
2.00
0.90
4.00
2.00
1.00
0.51

Melaleuca alternifolia
1.50
8.00
2.00
1.00
0.50
2.00
0.63
1.00
0.51

Mentha piperita
2.00
4.00
2.00
1.50
0.63
2.00
0.75
1.00
0.51

Myrtus communis
1.50
2.00
2.00
1.00
0.50
2.00
4.00
1.00
0.51

Ocimum basilicum
1.00
1.50
2.67
1.00
0.67
1.00
0.58
1.00
0.63

Origanum majorana
2.00
2.00
2.00
1.00
0.42
2.00
4.00
1.00
0.52

Pelargonium odoratissimum
0.75
1.50
2.00
1.25
1.04
2.00
1.17
1.00
0.52

Pinus sylvestris
1.50
4.00
2.00
1.00
0.50
2.00
0.75
2.00
1.00

Piper nigrum
2.00
2.00
2.00
1.00
0.42
2.00
1.00
1.00
0.57

Pogostemon patchouli
1.50
1.50
2.00
1.00
0.50
2.00
1.17
1.00
0.51

Rosmarinus officinalis
2.00
4.00
2.00
1.00
0.42
2.00
0.75
1.00
0.51

Salvia sclarea
0.88
2.00
3.50
1.00
0.73
2.00
1.00
1.00
0.51

Santalum album
2.00
0.25
0.50
1.00
0.42
1.00
2.25
1.00
0.51

Styrax benzoin
2.00
2.00
3.00
1.00
0.42
2.00
1.00
1.00
0.58

Syzygium aromaticum
0.50
1.50
1.50
0.50
0.58
2.00
1.17
1.00
0.53

Tagetes patula
2.00
4.00
1.50
1.00
0.42
2.00
0.75
1.00
0.51

Thymus vulgaris
1.00
3.33
2.00
1.00
0.67
1.00
0.40
1.00
0.51

Ciprofloxacin control
NR*

NR*

Amphotericin B control

NR*
NR*

NR*
NR*

*NR indicates not relevant; bold indicates synergy; MIC given in mg/mL.

Figure 1: Isobolograms constructed for the synergistic essential oil combinations against the pathogens C. albicans and S. aureus. ▲ indicates L. angustifolia essential oil in majority concentration, indicates other essential oils (D. carota or J. virginiana or C. zeylanicum or C. sinensis) in majority concentration, and * indicates equal ratios of essential oil in combination.

4. Discussion

Although a number of in vitro studies have been conducted on the antimicrobial activity of L. angustifolia essential oil against a wide variety of microorganisms, many studies have used disc diffusion assays to quantify antimicrobial activity, which later has been found to be largely inappropriate [20, 21]. The MIC method used for antimicrobial analysis of the essential oils is considered to be the preferred method, and as such, is the only one considered for comparative purposes here [22].

L. angustifolia has been extensively studied for antimicrobial effects against a variety of test microorganisms [23–33]. These previous studies have demonstrated the efficacy of this essential oil as an antimicrobial agent as well as augment the findings of this study. The essential oil from S. album has demonstrated notable activity in past studies. Superior antimicrobial activity (MIC value of 0.06% v/v) of S. album was observed when tested with a selection of 24 essential oils [25]. A later study by the same authors demonstrated activity for an Australian based S. album against C. albicans (MIC value of 0.06% v/v), P. aeruginosa (MIC value of >2.00 mg/mL), and S. aureus (MIC value of 0.12 mg/mL) [26]. The data from these studies are congruent with that reported here and demonstrate the antimicrobial potential of S. album.

The combination of L. angustifolia with D. carota against C. albicans in various ratios displayed a predominantly synergistic effect for eight of the ratios studied. For S. aureus, the tested ratios indicated mostly additive interactions. Where a higher concentration of D. carota essential oil was present in the oil mixture, a more favourable antimicrobial effect was noted. Lavandula angustifolia has been associated with the treatment of fungal infections and is also used in the treatment of Staphylococcal-related infections, such as boils and abscesses [6, 7]. No information could be obtained to support the use of D. carota for Staphylococcal and Candidal related infections, yet when the two essential oils are combined, the ratios where D. carota is in higher concentrations demonstrated a more favourable effect. This suggests that the presence of D. carota plays a role in the additive and synergistic findings observed against these microorganisms tested.

The combination of L. angustifolia and J. virginiana against C. albicans in various ratios indicated a synergistic effect for all nine of the ratios analysed. Against S. aureus, the ratios displayed a predominantly additive effect. Juniperus virginiana in combination with L. angustifolia essential oil has been implicated for the treatment of bacterial respiratory infections [5], while the combination was also noted for its use in the treatment of Candidal-type infections such as thrush [7]. Where the two essential oils are combined, regardless of ratio, the essential oils display synergistic effects for C. albicans.

The combination where L. angustifolia was combined with C. zeylanicum in various ratios against C. albicans displayed the greatest synergistic effect of all oils studied. It was also interesting to note that for these combinations, the higher the concentration of L. angustifolia, the more favourable (additive or synergistic) the interaction.Against S. aureus, the converse was true. Most of the ratios indicated an additive effect with one ratio (L. angustifolia: C. zeylanicum, 3 : 7) indicating synergy. The combination of C. zeylanicum and L. angustifolia has been associated with the treatment of topical infections and as a general antimicrobial agent [8]. This combination has demonstrated a greater antifungal effect when placed in various ratios as five of the nine ratios were synergistic against C. albicans. The ratios where L. angustifolia is in higher concentrations demonstrated a more favourable effect and this suggests that the presence of L. angustifolia plays a greater role in the synergy observed.

When L. angustifolia was combined with C. sinensis in various ratios, a predominantly synergistic effect was recorded for both microorganisms tested. The use of C. sinensis essential oil in combination with L. angustifolia for the treatment of respiratory infections has been documented [8]. Even though C. sinensis demonstrated poor activity when tested singularly [34, 35], when combined with L. angustifolia, efficacy was enhanced.

5. Conclusion

In summary, the analysis of the combination of L. angustifolia with a selection of other aroma-therapeutic essential oils has largely demonstrated noteworthy activity against the pathogens tested. The ΣFIC analysis indicated that these oils have favourable antimicrobial interactions when placed in combination, that is, 26.7% synergistic and 48.9% additive effects for selected oils. Only one combination (C. citratus in combination with L. angustifolia with a ΣFIC value of 6.67) demonstrated antagonistic effects. When placed in various ratios the combination of L. angustifolia and C. sinensis essential oil demonstrated the best antimicrobial effect with synergy identified for all ratios against the microorganisms tested. Essential oils blends have been used for many years for their curative properties and this study lends credibility to the frequent use of combining oils to achieve a superior therapeutic outcome.

Disclosure

No competing interests exist for the data obtained in this paper. The authors have not submitted the data for any other financial gain or secondary interest. This work has been generated for academic purposes only.

Acknowledgments

The authors are grateful to Robertet (France), Givaudan (Switzerland), and Clive Teubes cc (South Africa) for supplying the essential oils used in this study. The National Research Foundation is thanked for financial support.

References

T. Eveleigh, Lavender, Lorenz Books, Sydney, Australia, 1994.

C. J. Chu and K. J. Kemper, “Lavender (Lavandula spp.),” http://www.longwoodherbal.org/lavender/lavender.pdf

H. M. A. Cavanagh and J. M. Wilkinson, “Biological activities of lavender essential oil,” Phytotherapy Research, vol. 16, no. 4, pp. 301–308, 2002.

T. Dunning, “Caring for the wounded healer-nurturing the self,” Journal of Bodywork and Movement Therapies, vol. 10, no. 4, pp. 251–260, 2006.

J. Lawless, The Illustrated Encyclopedia of Essential Oils: The Complete Guide to the Use of Oils in Aromatherapy and Herbalism, Element Books Limited, Rockport, Mass, USA, 1995.

W. Sellar, The Directory of Essential Oils, C.W. Daniel Company Limited, London, UK, 1992.

S. Curtis, Essential Oils, Aurum Press, London, UK, 1996.

C. N. Shealy, The Illustrated Encyclopedia of Healing Remedies, Element Books, Rockport, Mass, USA, 1998.

P. Hili, The Antimicrobial Properties of Essential Oils, Winter Press, Kent, UK, 2001.

J. Buckle, Clinical Aromatherapy: Essential oils in Practice, Churchill Livingstone, London, UK, 2nd edition, 2003.

B. M. Lawrence, Antimicrobial Biological Activity of Essential Oils, Allured, Aurora, Ill, USA, 2005.

S. Cassella, J. P. Cassella, and I. Smith, “Synergistic antifungal activity of tea tree (Melaleuca alternifolia) and lavender (Lavandula angustifolia) essential oils against dermatophyte infection,” International Journal of Aromatherapy, vol. 12, no. 1, pp. 2–15, 2002.

V. Edwards-Jones, R. Buck, S. G. Shawcross, M. M. Dawson, and K. Dunn, “The effect of essential oils on methicillin-resistant Staphylococcus aureus using a dressing model,” Burns, vol. 30, no. 8, pp. 772–777, 2004.

S. F. Van Vuuren, G. P. P. Kamatou, and A. M. Viljoen, “Volatile composition and antimicrobial activity of twenty commercial frankincense essential oil samples,” South African Journal of Botany, vol. 76, no. 4, pp. 686–691, 2010.

S. De Rapper, S. F. Van Vuuren, G. P. P. Kamatou, et al., “The additive and synergistic antimicrobial effects of select frankincense and myrrh oils—a combination from the pharaonic pharmacopoeia,” Letters in Applied Microbiology, vol. 54, pp. 352–358, 2012.

CLSI and Clinical and Laboratory Standards Institute, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard M7-A6, National Committee for Clinical Laboratory Standards, Fort Wayne, Ind, USA, 6th edition, 2003.

J. E. Angeh, Biological characterization of isolated compounds [Ph.D. thesis], University of Pretoria, Pretoria, South Africa, 2006.

S. F. Van Vuuren and A. M. Viljoen, “Plant-based antimicrobial studies methods and approaches to study the interaction between natural products,” Planta Medica, vol. 77, no. 11, pp. 1168–1182, 2011.

S. Suliman, S. F. Van Vuuren, and A. M. Viljoen, “Validating the in vitro antimicrobial activity of Artemisia afra in polyherbal combinations to treat respiratory infections,” South African Journal of Botany, vol. 76, no. 4, pp. 655–661, 2010.

J. L. Ríos and M. C. Recio, “Medicinal plants and antimicrobial activity,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 80–84, 2005.

P. Cos, A. J. Vlietinck, D. Van den Berg, et al., “Anti-infective potential of natural products: how to develop a stronger in vitro ‘proof-of-concept’,” Journal of Ethnopharmacology, vol. 106, pp. 290–302, 2006.

D. Kalemba and A. Kunicka, “Antibacterial and antifungal properties of essential oils,” Current Medicinal Chemistry, vol. 10, no. 10, pp. 813–829, 2003.

R. R. S. Nelson, “In-vitro activities of five plant essential oils against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium,” Journal of Antimicrobial Chemotherapy, vol. 40, no. 2, pp. 305–306, 1997.

K. Adam, A. Sivropoulou, S. Kokkini, T. Lanaras, and M. Arsenakis, “Antifungal activities of origanum vulgare subsp. hirtum, Mentha spicata, Lavandula angustifolia, and Salvia fruticosa essential oils against human pathogenic fungi,” Journal of Agricultural and Food Chemistry, vol. 46, no. 5, pp. 1739–1745, 1998.

K. A. Hammer, C. F. Carson, and T. V. Riley, “In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp.,” Journal of Antimicrobial Chemotherapy, vol. 42, no. 5, pp. 591–595, 1998.

K. A. Hammer, C. F. Carson, and T. V. Riley, “Antimicrobial activity of essential oils and other plant extracts,” Journal of Applied Microbiology, vol. 86, no. 6, pp. 985–990, 1999.

S. Shin and S. Lim, “Antifungal effects of herbal essential oils alone and in combination with ketoconazole against Trichophyton spp.,” Journal of Applied Microbiology, vol. 97, no. 6, pp. 1289–1296, 2004.

L. Mayaud, A. Carricajo, A. Zhiri, and G. Aubert, “Comparison of bacteriostatic and bactericidal activity of 13 essential oils against strains with varying sensitivity to antibiotics,” Letters in Applied Microbiology, vol. 47, no. 3, pp. 167–173, 2008.

M. H. Lodhia, K. R. Bhatt, and V. S. Thaker, “Antibacterial activity of essential oils from palmarosa, evening primrose, lavender and tuberose,” Indian Journal of Pharmaceutical Sciences, vol. 71, no. 2, pp. 134–136, 2009.

V. Agarwal, P. Lal, and V. Pruthi, “Effect of plant oils on Candida albicans,” Journal of Microbiology, Immunology and Infection, vol. 43, no. 5, pp. 447–451, 2010.

M. Soković, J. Glamočlija, P. D. Marin, et al., “Antibacterial effects of the essential oils of commonly consumed medicinal herbs using an in vitro model,” Molecules, vol. 15, pp. 7532–7546, 2010.

T. H. Tsai, T. H. Tsai, W. H. Wu, J. T. P. Tseng, and P. J. Tsai, “In vitro antimicrobial and anti-inflammatory effects of herbs against Propionibacterium acnes,” Food Chemistry, vol. 119, no. 3, pp. 964–968, 2010.

A. Alexopoulos, A. C. Kimbaris, S. Plessas, et al., “Antibacterial activities of essential oils from eight Greek aromatic plants against clinical strains of Staphylococcus aureus,” Anaerobe, vol. 17, pp. 399–402, 2011.

S. Chao, G. Young, C. Oberg, and K. Nakaoka, “Inhibition of methicillin-resistant Staphylococcus aureus (MRSA) by essential oils,” Flavour and Fragrance Journal, vol. 23, no. 6, pp. 444–449, 2008.

C. A. O'Bryan, P. G. Crandall, V. I. Chalova, and S. C. Ricke, “Orange essential oils antimicrobial activities against Salmonella spp.,” Journal of Food Science, vol. 73, no. 6, pp. M264–M267, 2008.